TickerFacts.

Cencora, Inc. (COR): Cash & Equivalents

Annual figures by period end, from SEC filings.

$4.36B
As of 2025-09-30
$2.82B
As of 2026-06-30
+8.7%
3-year compound annual growth
-1.1%
5-year compound annual growth
+7.2%
10-year compound annual growth
$4.60B2007-09-30: $640.20M2008-09-30: $878.11M2009-09-30: $1.01B2010-09-30: $1.66B2011-09-30: $1.83B2012-09-30: $1.07B2013-09-30: $1.23B2014-09-30: $1.81B2015-09-30: $2.17B2016-09-30: $2.74B2017-09-30: $2.44B2018-09-30: $2.49B2019-09-30: $3.37B2020-09-30: $4.60B2021-09-30: $2.55B2022-09-30: $3.39B2023-09-30: $2.59B2024-09-30: $3.13B2025-09-30: $4.36B$4.36B
2007-09-30 Cash & Equivalents (USD) 2025-09-30
Period endedCash & EquivalentsChange YoYSource filing
2025-09-30$4.36B+39.1%2025-11-25, Balance as of period end
2024-09-30$3.13B+20.9%2025-11-25, Balance as of period end
2023-09-30$2.59B-23.5%2025-11-25, Balance as of period end
2022-09-30$3.39B+33.0%2024-11-26, Balance as of period end
2021-09-30$2.55B-44.6%2023-11-21, Balance as of period end
2020-09-30$4.60B+36.3%2022-11-22, Balance as of period end
2019-09-30$3.37B+35.4%2020-11-19, Balance as of period end
2018-09-30$2.49B+2.4%2019-11-19, Balance as of period end
2017-09-30$2.44B-11.2%2019-11-19, Balance as of period end
2016-09-30$2.74B+26.5%2018-11-20, Balance as of period end
2015-09-30$2.17B+19.8%2017-11-21, Balance as of period end
2014-09-30$1.81B+46.9%2016-11-22, Balance as of period end
2013-09-30$1.23B+15.4%2015-11-24, Balance as of period end
2012-09-30$1.07B-41.6%2014-11-25, Balance as of period end
2011-09-30$1.83B+10.1%2013-11-26, Balance as of period end
2010-09-30$1.66B+64.3%2012-11-27, Balance as of period end
2009-09-30$1.01B+14.9%2011-11-22, Balance as of period end
2008-09-30$878.11M+37.2%2010-11-23, Balance as of period end
2007-09-30$640.20Mn/a2009-11-25, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Cencora, Inc. (COR)2025-09-30$4.36B+39.1%
McKesson Corp (MCK)2026-03-31$3.98B-30.2%
Cardinal Health Inc (CAH)2026-06-30$4.86B+25.3%
Herbalife Ltd. (HLF)2025-12-31$353.10M-15.0%
Nu Skin Enterprises, Inc. (NUS)2025-12-31$238.63M+27.7%
Cosmos Health Inc. (COSM)2025-12-31$715.7K+127.1%
DataMeds AI, Inc. (MEDS)2025-12-31$42.6K-95.9%
HWH International Inc. (ESYN)2025-12-31$2.09M-52.0%

Compare COR, MCK, CAH, HLF side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗